Estos medicamentos estn aprobados por la FDA para el tratamiento de la obesidad, una enfermedad crnica que suele caracterizarse por un IMC de 30 o superior
(2022) Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial Chao Liao, et al
PMC 2633544
But coverage of weight loss treatments is less widespread, and navigating the complex insurance landscape can be challenging for patients and time consuming for doctors who prescribe the medications
Understanding GLP, G(C)LP and GCP GLP : Good Laboratory Practices refers to the regulations governing testing of new drugs before conducting clinical trials
Although a causal association with acute pancreatitis remains debated, observational studies suggest a higher incidence compared with placebo (Nieto et al., 2025